Top-News

Novo-Nordisk Aktie (ADR) News

Aktie
WKN:  866931 ISIN:  US6701002056 US-Symbol:  NVO Branche:  Pharmazeutika Land:  Dänemark
48,095 $
+0,095 $
+0,20%
41,329 € 18:24:39 Uhr
Depot/Watchlist
Marktkapitalisierung *
139,95 Mrd. €
Streubesitz
89,76%
KGV
27,28
Dividende
0,58 $
Dividendenrendite
1,22%
Faktor
1
Originalaktie
DK0062498333
Weiter aufwärts? Long handeln - Jetzt mit Hebel 9,86: UQ6G0Y
Werbung

Novo-Nordisk Aktie (ADR) News

09.09.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Nordisk A/S Lawsuit - NVO
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Nordisk A/S Lawsuit - NVO PR Newswire
08.09.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO PR ...
08.09.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVO PR Newswire
06.09.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk PR Newswire
06.09.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
05.09.25 - PR Newswire
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
05.09.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO PR Newswire
04.09.25 - PR Newswire
NYSE: NVO DEADLINE REMINDER: Berger Montague Reminds Nordisk A/S (NYSE: NVO) Investors of Important Class Action Lawsuit Deadline
NYSE: NVO DEADLINE REMINDER: Berger Montague Reminds Nordisk A/S (NYSE: NVO) Investors of Important Class Action Lawsuit Deadline PR Newswire
04.09.25 - PR Newswire
Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
03.09.25 - ARIVA.DE Redaktion
Novo Nordisk: War das etwa schon alles?
Die Erholung der Aktie von Novo Nordisk ist zum Erliegen gekommen. Brauchen Anlegerinnen und Anleger einfach nur Geduld oder ist Schlimmeres zu befürchten?
03.09.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO PR ...
03.09.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
02.09.25 - PR Newswire
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
02.09.25 - PR Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S(NVO) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S(NVO) Shareholders PR Newswire
02.09.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
28.08.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Contact The Gross Law Firm Before September 30, 2025 to Discuss Your Rights - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Contact The Gross Law Firm Before September 30, 2025 to Discuss Your Rights - NVO PR Newswire
27.08.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
27.08.25 - PR Newswire
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
27.08.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk PR Newswire
26.08.25 - PR Newswire
Investors who lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO
Investors who lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +2,17%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »